Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Zhangfu Fang (GuangZhou, China), Zhangfu Fang, Fagui Chen, Fang Yi, Huasi Zhao, Chuqin Huang, Chenhui Li, Jiaxing Xie, Kefang Lai, Nanshan Zhong. LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis. Eur Respir J 2016; 48: Suppl. 60, 3541

Member's Comments

No comment yet.

Related content which might interest you: The effect of trehalose for the allergen-induced airway hyperresponsiveness and airway inflamation in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 LSC 2014 abstract - RORgamma t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Absence of proton sensing OGR1 protects against house dust mite-induced allergic airway inflammation Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Dose-dependent differential effects of thrombin in allergic bronchial asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 IL-13 in a mouse model of chemical-induced airway hyperresponsiveness Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Syk mediates airway hyper-responsiveness and airway remodeling in a chronic mouse model of house dust mite induced allergic airways disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Beta2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation in mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Ciclesonide and tiotropium synergistically inhibit airway eosinophilia in a guinea pig model of chronic asthma Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Young Investigator session: ROR?t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014